Walleye Capital
BOLD

Walleye Capital’s Boundless Bio BOLD Stock Holding History

Walleye Capital’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-39,624
Closed -$43.6K – 5243
2026
Q1 		$43.6K Hold
39,624
– – ﹤0.01% 3934
2025
Q4 		$47.5K Hold
39,624
– – ﹤0.01% 4091
2025
Q3 		$48.7K Hold
39,624
– – ﹤0.01% 4008
2025
Q2 		$40K Hold
39,624
– – ﹤0.01% 4106
2025
Q1 		$59.8K Hold
39,624
– – ﹤0.01% 3791
2024
Q4 		$115K Hold
39,624
– – ﹤0.01% 4071
2024
Q3 		$137K Sell
39,624
-915
-2% -$3.32K ﹤0.01% 4243
2024
Q2 		$157K Buy
+40,539
New +$387K ﹤0.01% 4464

Other funds holding BOLD

CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.99% 1-Year Est. Return
FMP
Financial Management Professionals Austin, Texas $1.05B AUM 21.07% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Walleye Capital's BOLD Position: Q2 2026 in Review

Walleye Capital sold out of Boundless Bio (BOLD) in Q2 2026, closing a stake of 39,624 shares — an estimated $43.6K sold.

Walleye Capital first reported a position in BOLD in Q2 2024 and held it in 8 quarters. The position peaked at $157K in Q2 2024. 4 funds tracked by Wall St. Rank hold BOLD as of Q2 2026.

  • Walleye Capital reported no remaining Boundless Bio position as of Q2 2026 after selling out during the quarter.
  • Walleye Capital sold 39,624 Boundless Bio shares in Q2 2026, an estimated $43.6K.
  • Walleye Capital first reported a position in Boundless Bio in Q2 2024 and held it in 8 quarters.
  • Walleye Capital's Boundless Bio position peaked at $157K in Q2 2024.
  • 4 funds tracked by Wall St. Rank held Boundless Bio as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.